You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm is developing protein therapies incorporating synthetic amino acids coded for by "unnatural" base pairs developed at The Scripps Research Institute.
The company will work with a University of Copenhagen researcher to develop new synthetic peptide tools for the Syro Wave platform.
The firm sold its bioanalytical and genetic testing businesses to Bostwick Labs as it preps to buy peptide maker GL Biochem.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.